ArticleInternational urogynecology journal2026
Effects of Different Cystoscopic Bladder Conditions on the Therapeutic Outcomes of Intravesical Platelet-Rich Plasma Injections in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
Article in International urogynecology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
introduction and hypothesisPatients with interstitial cystitis/bladder pain syndrome (IC/BPS) may present with different cystoscopic bladder conditions. The current study investigated the treatment outcomes of repeated intravesical platelet-rich plasma (PRP) injections for various bladder conditions.
methodsThis study included 66 patients with IC/BPS, including five with Hunner's IC and 61 with non-Hunner's IC, who were not successfully managed with conventional treatments. The eligible patients underwent videourodynamic studies, completed voiding diaries, and received intravesical PRP injections once a month for a total of four treatments. Cystoscopic hydrodistention was performed, and the maximal bladder capacity and glomerulation grade were recorded. Treatment outcomes were examined using the global response assessment (GRA), and patients with a GRA score of 2 or 3 were considered to have achieved treatment success.
resultsIn total, 33 (50%) patients, including 20 (30.3%) who had an excellent outcome (GRA score of 3) and 13 (19.7%) who had moderate improvement (GRA score of 2), reported a successful outcome. The bladder pain visual analog score of 23 (34.8%) patients reduced by ≥ 3, and the functional bladder capacity of 15 (25.9%) patients increased to ≥ 350 mL. The glomerulation grade of 20 (32.8%) patients decreased by ≥ 1. All patients did not report adverse events such as urinary tract infection and urination difficulty. Patients with a baseline MBC of ≥ 760 mL and glomerulation grade of 0 or 1 had relatively higher success rates.
conclusionsIn 50% of patients with IC/BPS, including the non-Hunner's and Hunner's IC subtypes, intravesical PRP injections were effective in reducing bladder pain, increasing bladder capacity, and improving glomerulation grade after cystoscopic hydrodistention. Moreover, patients with reduced bladder inflammation who exhibited a low glomerulation grade and a larger maximal bladder capacity at baseline had a relatively higher treatment success rate.
Indexed as
Identifiers
42084645What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.